AsraKermaniMDFACP
Endocrinology • Dallas, TXDiabetes, Lipid Metabolism
Associate Professor, Internal Medicine, Division of Endocrinology, UT Southwestern Medical Center, Medical Director, Southwestern Health Resources
Dr. Kermani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-2800Fax+1 214-645-2808
Summary
- Dr. Asra Kermani is an endocrinologist in Dallas, TX. She received her medical degree from Aga Khan Medical College and has been in practice 25 years. She specializes in diabetes and lipid metabolism.
Education & Training
University of Texas Southwestern Medical SchoolPost-Doctoral Fellowship, 2005 - 2006
University of Texas Health Science Center at HoustonFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 1999- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1994 - 1997
Aga Khan Medical CollegeClass of 1992
Certifications & Licensure
TX State Medical License 2006 - 2026
PA State Medical License 1998 - 2008- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Publications & Presentations
PubMed
- 14 citationsIntegrating Patient Priorities with Science by Community Engagement in the Kidney Precision Medicine Project.Katherine R. Tuttle, Richard Knight, Paul S. Appelbaum, Tanima Arora, Shweta Bansal
Clinical Journal of the American Society of Nephrology. 2021-04-07 - 1 citationsImproving Diabetes Control Using Lean Six Sigma Quality Improvement in an Endocrine Clinic in a Large Accountable Care Organization.Usha Kollipara, Mario Rivera-Bernuy, Joseph Putra, Jessica Burks, Amber Meyer
Clinical Diabetes. 2021-01-01 - 5 citationsComparison of testosterone, alendronate, and a combination of both therapies in men with low bone mineral density.Brian J. Welch, Margo A. Denke, Asra Kermani, Beverley Adams-Huet, Nina M. Gazmen
Journal of Investigative Medicine. 2007-05-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
